News and Events

View our monthly calendar for upcoming innovation information sessions, seminars, symposia and other events hosted by Enterprise Innovation and selected ecosystem partners.

New Genetic Signatures Can Classify Breast Cancers and Guide Prognosis

October 4, 2024

Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients with breast cancer compared to previously developed genomic signatures.

The Englander Institute for Precision Medicine Receives Gift from Investment Firm to Support Its Innovative Cancer Therapeutic Research

October 4, 2024

The Medical Excellence Foundation (MEF) pledged to Weill Cornell Medicine a two-year, $200,000 philanthropic gift to support the work of Dr. Olivier Elemento, director of the Englander Institute for Precision Medicine (EIPM) and a professor of physiology and biophysics.

From Scientist to Entrepreneur: Dr. Annie De Groot Shared Her Personal Journey of Helping Discover Immune Boosting Drugs

September 17, 2024

From watching her father perform experiments in the laboratory to working alongside prominent researchers at the National Institutes of Health (NIH), Dr. Annie De Groot’s definition of ‘a physician scientist’ evolved to include entrepreneur. While building her career, she discovered a passion for translational immunology research and founded EpiVax, an immunoinformatics platform company that helps develop findings in the lab into therapeutics for clinical trials.

Dr. Paraskevi Giannakakou Named 2024 XSeed Award Winner

September 11, 2024

Dr. Paraskevi Giannakakou, professor of pharmacology in medicine, was one of the winners of the fourth annual XSeed Award, Cure announced in ceremonies in New York City on Sep. 10. The XSeed Award supports women- and minority-led life science startups in New York City by providing critical funding to bridge the gap from promising preclinical drug development research to the marketplace and commercial success. 

Preclinical Model Offers New Insights into Parkinson’s Disease Process

July 23, 2024

A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease in people, according to a study led by Weill Cornell Medicine researchers.

Prestigious MERIT Grant Funds Research on How the Immune System Can Banish HIV

July 17, 2024

Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to novel therapeutic strategies for thwarting or eliminating HIV. Dr. Brad Jones, associate professor of immunology in medicine in the Division of Infectious Diseases at Weill Cornell Medicine, was awarded a MERIT grant from the National Institute for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH).

Machine Learning Helps Define New Subtypes of Parkinson’s Disease

July 16, 2024

Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses. In addition to having the potential to become an important diagnostic and prognostic tool, these subtypes are marked by distinct driver genes. If validated, these markers could also suggest ways the subtypes can be targeted with new and existing drugs.

The research was published on July 10 in npj Digital Medicine.

Scientists Identify Blood Vessel Repair Cells

July 3, 2024

Endothelial cells with a distinct gene-expression signature play a key role in the development and repair of blood vessels throughout life, according to a new study by Weill Cornell Medicine investigators. 

Cornell Inventors Celebrated at Cross-Campus Event

July 1, 2024

At “Bearers of Innovation: A One Cornell Celebration,” the Center for Technology Licensing at Cornell University recognized researchers’ milestones in the intellectual property and commercialization process. In total, 105 Cornellians invented technologies that were licensed or optioned to industry partners during fiscal year 2023, and 54 lead inventors disclosed a technology for the first time during the same fiscal year.

New Predictors of Metastasis in Patients with Early-Stage Pancreatic Cancer

June 28, 2024

Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic cancer will spread to an individual’s liver or elsewhere, such as the lung.